A second endogenous cannabinoid that modulates long-term potentiation

@article{Stella1997ASE,
  title={A second endogenous cannabinoid that modulates long-term potentiation},
  author={Nephi Stella and Paul Schweitzer and Daniele Piomelli},
  journal={Nature},
  year={1997},
  volume={388},
  pages={773-778}
}
Cannabinoid receptors are molecular targets for marijuana and hashish, the widespread drugs of abuse. These receptors are expressed in areas of the central nervous system that contribute in important ways to the control of memory, cognition, movement and pain perception. Indeed, such functions can be strongly influenced by cannabinoid drugs, with consequences that include euphoria, analgesia, sedation and memory impairment. Although the pharmacology of cannabinoid drugs is now beginning to be… Expand
Functions of cannabinoid receptors in the hippocampus
TLDR
The effects of cannabinoids on hippocampal function are reviewed and the evidence that hippocampal cannabinoid receptors play a role in learning and formation of memory is evaluated. Expand
Cannabinoid modulation of neuronal activity in adult rat hippocampus.
TLDR
A second endogenous cannabinoid ligand, 2-arachidonylglycerol (2-AG), is found in brain and the levels of 2-AG markedly increase upon fiber tract stimulation in hippocampal slices, suggesting that 2- AG may act as a signaling molecule in hippocampus. Expand
Cannabis and the brain.
  • L. Iversen
  • Psychology, Medicine
  • Brain : a journal of neurology
  • 2003
TLDR
Central effects of cannabinoids include disruption of psychomotor behaviour, short-term memory impairment, intoxication, stimulation of appetite, antinociceptive actions (particularly against pain of neuropathic origin) and anti-emetic effects. Expand
The neurobiology and evolution of cannabinoid signalling.
  • M. Elphick, M. Egertová
  • Biology, Medicine
  • Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • 2001
TLDR
A model of cannabinoid signalling is presented in which anandamide is synthesized by postsynaptic cells and acts as a retrograde messenger molecule to modulate neurotransmitter release from presynaptic terminals, concluding that the cannabinoid signalling system may be quite restricted in its phylogenetic distribution. Expand
Mechanism of Cannabinoid Effects on Long-Term Potentiation and Depression in Hippocampal CA1 Neurons
TLDR
The results indicate that cannabinoid receptor activation does not directly inhibit the molecular mechanisms responsible for long-term synaptic plasticity but instead impairs LTP and LTD by reducing presynaptic neurotransmitter release to a level below that required to depolarize the postsynaptic membrane to relieve Mg2+ blockade of NMDA receptors. Expand
The effects of cannabinoids on the brain
  • A. Ameri
  • Medicine, Chemistry
  • Progress in Neurobiology
  • 1999
TLDR
Cannabinoids share a final common neuronal action with other major drugs of abuse such as morphine, ethanol and nicotine in producing facilitation of the mesolimbic dopamine system. Expand
Cardiovascular actions of cannabinoids and their generation during shock
TLDR
Recent studies indicate that a peripheral endogenous cannabinoid system in circulating macrophages and platelets is activated in hemorrhagic and septic shock and may contribute to the hypotension associated with these conditions via activation of vascular cannabinoid receptors. Expand
Control of pain initiation by endogenous cannabinoids
TLDR
It is shown that anandamide attenuates the pain behaviour produced by chemical damage to cutaneous tissue by interacting with CB1-like cannabinoid receptors located outside the CNS, and that locally generated an andamide and PEA may mediate this effect. Expand
Cannabinoid disruption of learning mechanisms involved in reward processing.
TLDR
Roles for endogenous cannabinoids in shaping synaptic activity in cortical and subcortical brain circuits are examined, and mechanisms in which exogenous cannabinoids, such as Δ9-THC, interact with endocannabinoid systems to disrupt neuronal network oscillations are discussed. Expand
Cannabinoid receptor signaling and modulation of monoamines: Implications for psychiatric and neurological disorders
  • E. V. Bockstaele
  • Psychology
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2012
The past decade has seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, new perspectives on the impact and consequences of cannabinoid modulation ofExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
The endogenous cannabinoid receptor agonist anandamide impairs memory in rats
Anandamide was recently discovered to be an endogenous substance that acts as a partial agonist at cannabinoid receptors in the central nervous system. Because exogenous cannabinoids such asExpand
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
TLDR
It is reported that anandamide is produced in and released from cultured brain neurons in a calcium ion-dependent manner when the neurons are stimulated with membrane-depolarizing agents, indicating that multiple biochemical pathways may participate in an andamide formation in brain tissue. Expand
The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
TLDR
It is demonstrated that anandamide produces effects in a tetrad of tests used to predict cannabimimetic activity and supports the contention of its role as an endogenous cannabinoid ligand. Expand
Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization.
TLDR
Evidence is provided that the endogenous ligand for the cannabinoid receptor can be released in response to a depolarizing stimulus (75 mM K+) in the presence of extracellular Ca++ and that these fractions could inhibit adenylate cyclase activity in neuroblastoma membrane preparations. Expand
Pharmacology of cannabinoid receptors.
  • A. Howlett
  • Biology, Medicine
  • Annual review of pharmacology and toxicology
  • 1995
TLDR
Two subtypes of cannabinoid receptors, CB1 and CB2, have been described to date, although future investigations may elucidate other receptors, and three classes of agonist ligands regulate cannabinoid receptors: cannabinoid, aminoalkyl-indole, and eicosanoid derivatives. Expand
Cannabinoid receptor localization in brain.
  • M. Herkenham, A. Lynn, +4 authors K. Rice
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1990
TLDR
The potencies of a series of natural and synthetic cannabinoids as competitors of [3H]CP 55,940 binding correlated closely with their relative potencies in several biological assays, suggesting that the receptor characterized in the in vitro assay is the same receptor that mediates behavioral and pharmacological effects of cannabinoids, including human subjective experience. Expand
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
TLDR
2-Arachidonoylglycerol was shown to bind appreciably to the cannabinoid receptor in competitive inhibition experiments and may be an endogenous cannabinoid receptor ligand in the brain. Expand
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Arachidonylethanolamide, an arachidonic acid derivative in porcine brain, was identified in a screen for endogenous ligands for the cannabinoid receptor. The structure of this compound, which hasExpand
Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP
TLDR
The results thus indicate that NAPE levels in cortical neurons are controlled by Ca2+ ions and cAMP, and regulatory effect may participate in maintaining a supply of cannabimimetic N-acylethanolamines during synaptic activity, and prime target neurons for release of these bioactive lipids. Expand
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
TLDR
The distribution of anandamide in human brain and spleen supports its potential role as an endogenous agonist in central and peripheral tissues and suggests that it is metabolized in tissues where it is synthesized, and that its action is probably not hormonal in nature. Expand
...
1
2
3
4
5
...